Walking Gait Biomechanics Following Knee Joint Effusion
Characterizing Changes in Knee Joint Loading With Wearable Sensor Technology Following an Experimental Knee Joint Effusion
1 other identifier
interventional
14
1 country
1
Brief Summary
The purpose of this study is to determine the sensitivity of a wearable sensor to detect changes in knee joint loading using an experimental knee joint effusion as a model for a common clinical physiological alteration in joint status. The rationale for this project is that it will establish the efficacy of an inexpensive, clinically, and publicly available device that can detect changes in biomechanical loading due to acute physiologic change in joint status. The study will utilize a cross-sectional cohort study design and will seek to enroll 25 male and female healthy adult participants (18-35 yo). Participants will report to the laboratory for three total sessions (Session 1: informed consent and task familiarization; Session 2: testing; Session 3: knee joint status assessment). The primary outcomes of interest include lower extremity thigh and shank acceleration and velocity data (wearable sensor data), lower extermity 3D kinematics and kinetics (motion capture data), and lower extremity muscle function (EMG data) during walking gait, as well as functional balance and patient-reported subjective outcomes. Data will be analyzed by calculating change scores from the pre- to post-experimental effusion outcome measure testing. Paired-samples t-tests and Cohen's d effect sizes will be used to assess changed in wearable sensor data from pre- to post-experimental effusion. Correlation statistics will be used to determine if there are association between the motion capture and wearable sensor data. The potential risks associated with an experimental joint effusion will be addressed by maintaining appropriate sterile conditions and having the participant check-in with the PI (licensed healthcare provider) at 48 hours following testing session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2019
CompletedFirst Posted
Study publicly available on registry
January 15, 2019
CompletedStudy Start
First participant enrolled
January 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 18, 2023
CompletedJanuary 22, 2026
February 1, 2025
4.3 years
January 11, 2019
January 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in Peak Vertical Ground Reaction Force
Kinetic Loading Variable
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Peak Internal Knee Extension Moment
Kinetic Loading Variable
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Peak Knee Power
Kinetic Loading Variable
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Shank Acceleration
Accelerometer Variable
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Thigh Acceleration
Accelerometer Variable
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Shank Angular Velocity
Gyroscope Variable
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Thigh Angular Velocity
Gyroscope Variable
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Secondary Outcomes (4)
Change in Quadriceps EMG
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Hamstring EMG
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in Visual Analog Scale Pain
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Change in International Knee Documentation Committee
Immediately Pre- (10 minutes) and Post- (10 minutes) Effusion
Study Arms (1)
Knee Joint Effusion
EXPERIMENTALParticipants will receive a one-time injection of 60mL of sterile saline into the suprapatellar space of the dominant lower extremity. This injection will be conducted under ultrasound guidance by a board-certified orthopedic surgeon.
Interventions
60mL saline injection into the supra-patellar region of the knee
Eligibility Criteria
You may qualify if:
- Male and female
- Chronological age 18-35 at the time of study participation
- Physically active (at least 30 minutes of physical activity, 3x/week)
- Tegner Activity Scale score at least 5/10
You may not qualify if:
- History of lower extremity or lumbar spine surgery.
- History of lower extremity or lumbar spine injury in the prior 6 months.
- History of major ligamentous damage.
- Current knee pain.
- Known neurological condition, autoimmune condition, cardiovascular disease.
- History of epilepsy, seizures, concussion within the prior 6 months.
- Currently taking pain altering medication.
- Fear of needles
- Unable to read and understand English language
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Michael W. Krzyzewski Human Performance Laboratory
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2019
First Posted
January 15, 2019
Study Start
January 29, 2019
Primary Completion
May 18, 2023
Study Completion
May 18, 2023
Last Updated
January 22, 2026
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share